Rodman & Renshaw Reiterates NeoStem Market Outperform, $3 PT

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Rodman & Renshaw reiterated its NeoStem (NYSE: NBS) Market Outperform and $3 price target in a research report published today.In the report, Rodman & Renshaw states, "According to our projections, NeoStem should have $16 MM in cash and cash equivalents when reporting 2Q11 results, with approximately 95 MM basic shares outstanding and 152 MM fully dilutive shares of outstanding. Together with an $18 MM equity line of credit, the cash position should be sufficient to fund operations through 1Q12."Shares of NeoStem were trading at $1.05 at the time of posting, down 0.94% from Tuesday's market close.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!